Manager × security

K2 PRINCIPAL FUND, L.P. SPRY holdings history

Who else holds this security? →

ARS PHARMACEUTICALS INC · CUSIP 82835W108 · CIK 1461790

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, K2 PRINCIPAL FUND, L.P. reported 375.13K SPRY (shares), valued at $3.00M, or 0.28% of its reported non-derivative portfolio. Filed 2026-08-07.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
0.28%
Shares
375.13K
375,132
Reported value
$3.00M
USD

Shares decreased 32.98%; reported value decreased 33.14%, and weight changed -0.19 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20260.28%375,132SEC filing ↗Filed Aug 7, 2026
Q1 20260.47%559,697SEC filing ↗Filed May 14, 2026
Q4 20250.01%10,200SEC filing ↗Filed Feb 13, 2026
Q3 20250.66%621,807SEC filing ↗Filed Nov 13, 2025
Q2 20251.01%317,126SEC filing ↗Filed Aug 14, 2025
Q1 20250.93%485,355SEC filing ↗Filed May 15, 2025
Q4 2024Not reportedNot reported—
Q3 20240.29%120,000SEC filing ↗Filed Nov 15, 2024
Q2 20244.63%2,461,672SEC filing ↗Filed Aug 14, 2024
Q1 20245.41%2,219,131SEC filing ↗Filed May 14, 2024
Q4 20233.92%3,054,333SEC filing ↗Filed Feb 14, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20233.92%3,054,333$16.74MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 14, 2024
Q1 20245.41%2,219,131$22.68MShares decreased 27.34%; reported value increased 35.50%, and weight changed +1.49 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2024
Q2 20244.63%2,461,672$20.95MShares increased 10.93%; reported value decreased 7.63%, and weight changed -0.78 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20240.29%120,000$1.74MShares decreased 95.13%; reported value decreased 91.69%, and weight changed -4.34 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 15, 2024
Q4 2024Not reported——This security is absent from this quarter's filing; a missing record is not treated as zero holdings.—
Q1 20250.93%485,355$6.11MA comparable prior-quarter record is unavailable; changes are not inferred.SEC filing ↗
Filed May 15, 2025
Q2 20251.01%317,126$5.53MShares decreased 34.66%; reported value decreased 9.37%, and weight changed +0.08 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20250.66%621,807$6.25MShares increased 96.08%; reported value increased 12.93%, and weight changed -0.35 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2025
Q4 20250.01%10,200$118.83KShares decreased 98.36%; reported value decreased 98.10%, and weight changed -0.65 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 13, 2026
Q1 20260.47%559,697$4.49MShares increased 5387.23%; reported value increased 3682.18%, and weight changed +0.46 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2026
Q2 20260.28%375,132$3.00MShares decreased 32.98%; reported value decreased 33.14%, and weight changed -0.19 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 7, 2026
K2 PRINCIPAL FUND, L.P. · ARS PHARMACEUTICALS INC

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1461790","quarter":"2026Q2","cusip":"82835W108"}

get_institutional_manager_history
{"cik":"1461790","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.